>AT4G02930.1 | elongation factor Tu putative / EF-Tu putative
MASVVLRNPSSKRLVPFSSQIYSRCGASVTSSYSISHSIGGDDLSSSTFGTSSFWRSMAT
FTRNKPHVNVGTIGHVDHGKTTLTAAITKVLAEEGKAKAIAFDEIDKAPEEKKRGITIAT
AHVEYETAKRHYAHVDCPGHADYVKNMITGAAQMDGGILVVSGPDGPMPQTKEHILLARQ
VGVPSLVCFLNKVDVVDDPELLELVEMELRELLSFYKFPGDDIPIIRGSALSALQGTNDE
IGRQAILKLMDAVDEYIPDPVRVLDKPFLMPIEDVFSIQGRGTVATGRIEQGVIKVGEEV
EILGLREGGVPLKSTVTGVEMFKKILDNGQAGDNVGLLLRGLKREDIQRGMVIAKPGSCK
TYKKFEAEIYVLTKDEGGRHTAFFSNYRPQFYLRTADITGKVELPENVKMVMPGDNVTAV
FELIMPVPLETGQRFALREGGRTVGAGVVSKVMT*
>AT4G11160.1 | translation initiation factor IF-2 mitochondrial putative
MPSFLSSLFGLGIQASFRIGLVLPRVVASTERQISSTVLKRASESVSFSFAPYINGFGFS
SLSNWSRSYESFPTETSIRYFHASRETLAKRKEDADRLLSHRERKKQTVKTKGKFSKREK
KTDKPPVEAPYVPPRLKRLAKGLPGKTVDIFEGMTLLELSKRTGESVAVLQSILINVGET
FSSEFDTISVDVAELLAMEIGINVRRQHSTEGSEILPRPPVVTVMGHVDHGKTSLLDALR
NTSVAAREAGGITQHVGAFVVGMPDSGTSITFLDTPGHAAFSEMRARGAAVTDIVVLVVA
ADDGVMPQTLEAIAHARSANVPVVVAINKCDKPGANPEKVKYQLTSEGIELEDIGGNVQA
VEVSAAKSTGLDKLEEALLLQAVDMDLKARVDGPAQAYVVEARLDKGRGPLATIIVKAGT
LVRGQHVVIGCQWGRLRAIRDMIGKTTDRATPAMPVEIEGLKGLPMAGDDVIVVESEERA
RMLSEGRKRKYEKDRLLKAEEARLEEAAARLETESEEGFVRVELPIVVKSDVQGTAQAVA
DALRTLNSPQVSVNIVHSGVGAISHSDLDLAQACGACIVGFNVKGGSTGNLSAAQGSVKV
FHHRVIYHLLEDIGNLIVEKAPGVSEMEVSGEAEVLSIFKILGKRRTEEDGVNIAGCKVM
DGRVCRSGLMRLLRSGEVVFEGSCASLKREKQDVEQVGKGNECGLVFGDWNDFRVGDVIQ
CMEPVIRKPKFISSESGAVRIEC*
>AT4G01370.1 | ATMPK4 (ARABIDOPSIS THALIANA MAP KINASE 4) MAP kinase/ kinase
MSAESCFGSSGDQSSSKGVATHGGSYVQYNVYGNLFEVSRKYVPPLRPIGRGAYGIVCAA
TNSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAVKDIIKPPQRENFNDV
YIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN
CDLKLGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGETMTR
EPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSA
GAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPVCVRPFNFDFEQPTLTEENIK
ELIYRETVKFNPQDSV*
>AT1G80410.1 | EMB2753 (EMBRYO DEFECTIVE 2753) binding
MGASLPPKEANLFKLIVKSYETKQYKKGLKAADAILKKFPDHGETLSMKGLTLNCMDRKT
EAYELVRLGVKNDIKSHVCWHVLGLLYRSDREYREAIKCYRNALRIDPDNLEILRDLSLL
QAQMRDLSGFVETRQQLLTLKPNHRMNWIGFAVSQHLNANASKAVEILEAYEGTLEDDYP
PENELIEHTEMILYKVSLLEESGSFDKALEELHKKEPKIVDKLSYKEQEVSLLSKVGRLE
EANKLYRVLLSMNPDNYRYHEGLQKCLGLYSESGQYSSDQIEKLNALYQSLSEQYTRSSA
VKRIPLDFLQDENFKEAVAKYIKPLLTKGVPSLFSDLSSLYDHPRKPDILEQLVVEMKHS
IGTTGSFPGSDVKEPPSTLLWTLFFLAQHYDRRGQYDVALCKIDEAIAHTPTVIDLYSVK
SRIMKHAGDLTAAAALADEARGMDLADRYINSECVKRMLQADQVPLAEKTAVLFTKEGDQ
LNNLHDMQCMWYDLASGDSYFRQGDLGRALKKFLAVEKHYADISEDQFDFHSYCLRKMTL
RSYVDMLKFQDRLHSFPYFHKAAIRAIRCYLKLHDSPKSTAGEDEMSKLAPAQKKKIKKQ
KKAEARAKKEAESKSEESTASGASKSGKRNVKPVDPDPHGQKLIQVEEPMAEASKYLRLL
QKHSPNSLETHLLSFEVNMRKQKFLLAFQAVKQLLKLGAENPDSHRSLVKFFLMTESISA
PTTEAEKLRWRVLEAERPSISQLQNKSLMEANKEFLGRHEDSLVHRAAYAEMLYILDPSK
KTEAIKIIEDSTNKVVQTNEALGQAREWKLKDCIAVHTLLDTVLLDSQAASRWKSRCAEY
FPCSTHFEGKHCSLMPDSVYNSSRKSNENGDTPNHPMGQTELSDGQLEAFKSLSVAT*
>AT5G13780.1 | GCN5-related N-acetyltransferase putative
MVCIRRATVDDLLAMQACNLMCLPENYQMKYYLYHILSWPQLLYVAEDYNGRIVGYVLAK
MEEESNECHGHITSLAVLRTHRKLGLATKLMTAAQAAMEQVYEAEYVSLHVRRSNRAAFN
LYTETLGYKINDVEAKYYADGEDAYDMRKNLKGKQNHHHAHGHHHHHGGGCCSGDAKVVE
TAQAVDGKAVSK*
>AT2G16880.1 | pentatricopeptide (PPR) repeat-containing protein
MATLKPPESQLLKTLTSILTSEKTHFLETLNPYIPQITQPLLTSLLSSPSLAKKPETLVS
FFQWAQTSIPEAFPSDSPLPLISVVRSLLSHHKFADAKSLLVSYIRTSDASLSLCNSLLH
PNLHLSPPPSKALFDIALSAYLHEGKPHVALQIFQKMIRLKLKPNLLTCNTLLIGLVRYP
SSFSISSAREVFDDMVKIGVSLNVQTFNVLVNGYCLEGKLEDALGMLERMVSEFKVNPDN
VTYNTILKAMSKKGRLSDLKELLLDMKKNGLVPNRVTYNNLVYGYCKLGSLKEAFQIVEL
MKQTNVLPDLCTYNILINGLCNAGSMREGLELMDAMKSLKLQPDVVTYNTLIDGCFELGL
SLEARKLMEQMENDGVKANQVTHNISLKWLCKEEKREAVTRKVKELVDMHGFSPDIVTYH
TLIKAYLKVGDLSGALEMMREMGQKGIKMNTITLNTILDALCKERKLDEAHNLLNSAHKR
GFIVDEVTYGTLIMGFFREEKVEKALEMWDEMKKVKITPTVSTFNSLIGGLCHHGKTELA
MEKFDELAESGLLPDDSTFNSIILGYCKEGRVEKAFEFYNESIKHSFKPDNYTCNILLNG
LCKEGMTEKALNFFNTLIEEREVDTVTYNTMISAFCKDKKLKEAYDLLSEMEEKGLEPDR
FTYNSFISLLMEDGKLSETDELLKKFSGKFGSMKRDLQVETEKNPATSESKEELNTEAIA
YSDVIDELCSRGRLKEHSRSYTS*
>AT1G68930.1 | pentatricopeptide (PPR) repeat-containing protein
MASNYYSVQIKQCIGLGARNQSRYVKMIHGNIIRALPYPETFLYNNIVHAYALMKSSTYA
RRVFDRIPQPNLFSWNNLLLAYSKAGLISEMESTFEKLPDRDGVTWNVLIEGYSLSGLVG
AAVKAYNTMMRDFSANLTRVTLMTMLKLSSSNGHVSLGKQIHGQVIKLGFESYLLVGSPL
LYMYANVGCISDAKKVFYGLDDRNTVMYNSLMGGLLACGMIEDALQLFRGMEKDSVSWAA
MIKGLAQNGLAKEAIECFREMKVQGLKMDQYPFGSVLPACGGLGAINEGKQIHACIIRTN
FQDHIYVGSALIDMYCKCKCLHYAKTVFDRMKQKNVVSWTAMVVGYGQTGRAEEAVKIFL
DMQRSGIDPDHYTLGQAISACANVSSLEEGSQFHGKAITSGLIHYVTVSNSLVTLYGKCG
DIDDSTRLFNEMNVRDAVSWTAMVSAYAQFGRAVETIQLFDKMVQHGLKPDGVTLTGVIS
ACSRAGLVEKGQRYFKLMTSEYGIVPSIGHYSCMIDLFSRSGRLEEAMRFINGMPFPPDA
IGWTTLLSACRNKGNLEIGKWAAESLIELDPHHPAGYTLLSSIYASKGKWDSVAQLRRGM
REKNVKKEPGQSWIKWKGKLHSFSADDESSPYLDQIYAKLEELNNKIIDNGYKPDTSFVH
HDVEEAVKVKMLNYHSERLAIAFGLIFVPSGQPIRVGKNLRVCVDCHNATKHISSVTGRE
ILVRDAVRFHRFKDGTCSCGDFW*